Core Viewpoint - The company has announced the completion of two fundraising investment projects and plans to permanently supplement its working capital with the remaining funds, which will enhance operational efficiency and benefit all shareholders [1][2]. Group 1: Project Completion - The company will hold its sixth board and supervisory meeting on December 6, 2025, to approve the completion of the "Annual Production of 120 Tons of Raw Materials Project" and the "Intelligent Specialty Raw Material Pharmaceutical Supporting Industry Chain Project" [1]. - The "Annual Production of 120 Tons of Raw Materials Project" had a planned investment of 264 million yuan, with 136 million yuan already invested [1]. - The "Intelligent Specialty Raw Material Pharmaceutical Supporting Industry Chain Project" had a planned investment of 100 million yuan, with 36.759 million yuan already invested [1]. Group 2: Financial Implications - The remaining funds from the completed projects, including interest income and cash management returns, will be used to permanently supplement the company's working capital [1][2]. - This move is expected to meet the company's daily operational needs and improve overall operational efficiency [2].
新天地：拟将募投项目结项并将结余资金用于永久补充流动资金